Perrigo Company plc (0Y5E.L)

29,95 -0,10 (-0,33%) Alla chiusura: 06:19PM BST

Perrigo Company plc

The Sharp Building
Hogan Place
Dublin D02 TY74
Ireland
353 1 709 4000
https://www.perrigo.com

Settore/i: 
Settore: 
Impiegati a tempo pieno: 9.140

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Patrick Lockwood-Taylor	President, CEO & Director	2,37M	N/D	N/D
Mr. Eduardo Guarita Bezerra	Executive VP & CFO	1,2M	N/D	1976
Mr. Ronald C. Janish	Chief Transformation Officer and Executive VP of Global Operations & Supply Chain	1,36M	N/D	1966
Ms. Kyle L. Hanson	Executive VP, General Counsel & Corporate Secretary	943,95k	N/D	1965
Mr. Svend Andersen	Executive VP & President of Consumer Self-Care International	1,11M	N/D	1962
Mr. Shannon Hukill	Senior Director of Technical Operations	N/D	N/D	N/D
Mr. Thomas M. Farrington	Chief Information Officer & Executive VP	N/D	N/D	1957
Ms. Alison Ives	Executive VP & Chief Scientific Officer	N/D	N/D	1981
Mr. Bradley Joseph	Vice President of Global Investor Relations & Corporate Communications	N/D	N/D	N/D
Ms. Mary Reilly-Brest	Director of Global Organizational and Human Resource Development	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Governance aziendale

L'ISS Governance QualityScore di Perrigo Company plc al 1 aprile 2024 è 2. I criteri di valutazione fondamentali sono revisione: 6; Consiglio di Amministrazione: 1; diritti degli azionisti: 1; retribuzione: 5.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.